Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
8
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
8
×
indiana blog main
indiana top stories
life sciences
national
8
×
national blog main
national top stories
new york blog main
new york top stories
pfizer
8
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
eli lilly
investing
startups
astrazeneca
cancer
clinical trials
deals
merck
alzheimer's disease
bristol-myers squibb
What
bio
8
×
roundup
8
×
develop
amid
biotech
bombast
cancer
caught
companies
coronavirus
days
debate
discussion
drug
drugs
efforts
fda
growing
life
meso’s
miss
news
pandemic
pfizer’s
presidential
promise
response
science
tuesday’s
vaccine
viewers
week
alliance
alzheimer’s
annual
approved
arena’s
assessed
attention
august
Language
unset
Current search:
fda
×
roundup
×
" boston top stories "
×
national
×
bio
×
pfizer
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More